EG18749A - Process for preparing cephalosporin salts and injectable compositions - Google Patents

Process for preparing cephalosporin salts and injectable compositions

Info

Publication number
EG18749A
EG18749A EG2189A EG2189A EG18749A EG 18749 A EG18749 A EG 18749A EG 2189 A EG2189 A EG 2189A EG 2189 A EG2189 A EG 2189A EG 18749 A EG18749 A EG 18749A
Authority
EG
Egypt
Prior art keywords
injectable compositions
preparing cephalosporin
cephalosporin salts
salts
preparing
Prior art date
Application number
EG2189A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22510643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG18749(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of EG18749A publication Critical patent/EG18749A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EG2189A 1988-01-19 1989-01-18 Process for preparing cephalosporin salts and injectable compositions EG18749A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/144,899 US4910301A (en) 1985-08-05 1988-01-19 Cefepime cephalosporin salts

Publications (1)

Publication Number Publication Date
EG18749A true EG18749A (en) 1993-12-30

Family

ID=22510643

Family Applications (1)

Application Number Title Priority Date Filing Date
EG2189A EG18749A (en) 1988-01-19 1989-01-18 Process for preparing cephalosporin salts and injectable compositions

Country Status (32)

Country Link
US (1) US4910301A (hu)
JP (1) JPH0725768B2 (hu)
KR (1) KR950003612B1 (hu)
AT (1) AT399878B (hu)
AU (1) AU615509B2 (hu)
BE (1) BE1002749A5 (hu)
CA (1) CA1298288C (hu)
CY (1) CY1663A (hu)
CZ (1) CZ281602B6 (hu)
DD (2) DD283397A5 (hu)
DE (1) DE3901359A1 (hu)
DK (1) DK162054C (hu)
EG (1) EG18749A (hu)
ES (1) ES2012948A6 (hu)
FI (1) FI86854C (hu)
FR (1) FR2626003B1 (hu)
GB (1) GB2213819B (hu)
GR (1) GR1001218B (hu)
HK (1) HK72292A (hu)
HU (1) HU205940B (hu)
IE (1) IE67447B1 (hu)
IT (1) IT1229528B (hu)
LU (1) LU87432A1 (hu)
NL (1) NL192266C (hu)
NZ (1) NZ227605A (hu)
OA (1) OA09227A (hu)
PT (1) PT89474B (hu)
SE (1) SE505258C2 (hu)
SG (1) SG75492G (hu)
SK (1) SK281768B6 (hu)
YU (1) YU221188A (hu)
ZA (1) ZA89407B (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
DE68917574T2 (de) * 1988-12-27 1994-12-15 Chugai Pharmaceutical Co Ltd Reinigungsverfahren für 1,2-Bis(nicotinamido)propan.
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
MY108872A (en) * 1991-09-10 1996-11-30 Bristol Myers Squibb Co Preparation of a cephalosporin antibiotic using the syn-isomer of a thiazolyl intermediate.
US5594129A (en) * 1991-09-10 1997-01-14 Bristol-Myers Squibb Company Process for the preparation of a cephalosporin antibiotic
YU81692A (sh) * 1991-09-10 1995-03-27 Bristol-Myers Co. Postupak za proizvodnju cefalosporinskog antibiotika
US5698703A (en) * 1991-09-10 1997-12-16 Bristol-Myers Squibb Company Syn-isomer of thiazolyl intermediate and process for the preparation thereof
CA2099692C (en) * 1992-07-24 2003-09-30 Gary M. F. Lim Process for preparing cephalosporin intermediates
US5401842A (en) * 1992-09-08 1995-03-28 Bristol-Myers Squibb Company Injectable compositions of a cephalosporin dihydrate salt
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
US5391729A (en) * 1992-09-08 1995-02-21 Bristol-Myers Squibb Company Crystalline dihydrate of a cephalosporin salt
JPH0840907A (ja) 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
WO2005094800A2 (en) * 2004-03-31 2005-10-13 Lupin Ltd. A co-precipitated cefepime composition and process for preparation thereof
WO2006008749A1 (en) * 2004-07-16 2006-01-26 Hetero Drugs Limited Process for preparing pure cephalosporine intermediates
ITMI20051684A1 (it) * 2005-09-13 2007-03-14 Harvest Lodge Ltd Procedimento per la produzione del dicloridrato di amminoacidi
ITMI20060422A1 (it) * 2006-03-09 2007-09-10 Harvest Lodge Ltd Procedimento diretto per la produzione del dicloridrato di un amminoacido
US8151846B2 (en) * 2006-12-15 2012-04-10 Center Line Wheel Corporation Wheel having inner bead-lock
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
CN103304580B (zh) * 2013-06-09 2014-07-09 四川省惠达药业有限公司 一种盐酸头孢吡肟化合物、其制备方法及其药物组合物
AU2016367284C1 (en) * 2015-12-10 2018-09-20 Naeja-Rgm Pharmaceuticals Ulc Cephem compounds, their production and use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
GB2052490B (en) * 1979-05-25 1983-09-07 Glaxo Group Ltd Intermediates for use in the preparation of cephalosporin antibiotics
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4751295A (en) * 1984-04-09 1988-06-14 Bristol-Myers Company Cephalosporin derivatives
US4749694A (en) * 1984-04-26 1988-06-07 Merck & Co., Inc. Novel lysine esters used as absorption
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
US4791196A (en) * 1986-09-26 1988-12-13 Sankyo Company Limited Crystalline cephem carboxylic acid addition salt

Also Published As

Publication number Publication date
DE3901359A1 (de) 1989-10-05
ATA8589A (de) 1994-12-15
GB2213819A (en) 1989-08-23
HK72292A (en) 1992-10-02
JPH0725768B2 (ja) 1995-03-22
SE505258C2 (sv) 1997-07-21
FI86854C (fi) 1992-10-26
SG75492G (en) 1992-10-02
OA09227A (fr) 1992-06-30
JPH029885A (ja) 1990-01-12
FI86854B (fi) 1992-07-15
FI890213A0 (fi) 1989-01-16
IT8947539A0 (it) 1988-01-17
CA1298288C (en) 1992-03-31
FR2626003B1 (fr) 1992-10-16
DK162054C (da) 1992-02-10
GR1001218B (el) 1993-06-21
GB2213819B (en) 1991-11-27
SK24389A3 (en) 2000-12-11
SE8900173D0 (sv) 1989-01-18
NL8900111A (nl) 1989-08-16
SK281768B6 (sk) 2001-07-10
CZ24389A3 (en) 1996-08-14
KR950003612B1 (ko) 1995-04-17
FI890213A (fi) 1989-07-20
ZA89407B (en) 1989-09-27
DK20789A (da) 1989-07-20
BE1002749A5 (fr) 1991-05-28
AT399878B (de) 1995-08-25
SE8900173L (en) 1989-01-18
HU205940B (en) 1992-07-28
DE3901359C2 (hu) 1992-04-30
PT89474A (pt) 1990-02-08
NL192266B (nl) 1996-12-02
HUT50347A (en) 1990-01-29
YU221188A (en) 1990-04-30
FR2626003A1 (fr) 1989-07-21
DD284807A5 (de) 1990-11-28
NZ227605A (en) 1991-06-25
GB8901073D0 (en) 1989-03-15
DK20789D0 (da) 1989-01-18
IT1229528B (it) 1991-09-04
LU87432A1 (fr) 1989-08-30
NL192266C (nl) 1997-04-03
CZ281602B6 (cs) 1996-11-13
IE890144L (en) 1989-07-19
KR890011895A (ko) 1989-08-23
AU2862389A (en) 1989-07-20
IE67447B1 (en) 1996-04-03
DK162054B (da) 1991-09-09
DD283397A5 (de) 1990-10-10
US4910301A (en) 1990-03-20
PT89474B (pt) 1993-12-31
CY1663A (en) 1993-05-14
ES2012948A6 (es) 1990-04-16
AU615509B2 (en) 1991-10-03

Similar Documents

Publication Publication Date Title
EG18749A (en) Process for preparing cephalosporin salts and injectable compositions
ZA895588B (en) Intravenou pharmaceutical composition and process for preparing the same
HUT53102A (en) Process for producing new quinuclidine derivatives and pharmaceutical compositions comprising same
GR900100568A (en) A method for preparing a composition in the form of microparticles
HK18396A (en) Cephem compound and a process for preparation thereof
HUT57237A (en) Process for producing glucosaminoglucanic salts and pharmaceutical compositions comprising same
HU896499D0 (en) Process for the preparation of piperidine derivatives
HUT39746A (en) Process for producing cephalosporin derivatives and pharmaceutical compositions containing them
EG18003A (en) Cephalosporin salts and injectable compositions
HUT56567A (en) Process for producing lactam derivatives and pharmaceuitcal compositions comprising such compounds
HUT49487A (en) Process for stabilizing cephalosporins
IL96249A0 (en) Injectable solution and process for preparing same
ZA892089B (en) Cephalosporin derivatives and processes for their preparation
PT80294A (en) Process for preparing cephalosporin derivatives and salts thereof
GB8715337D0 (en) Preparing cephalosporin derivatives
EP0362686A3 (en) Method for preparing the (+)-isomer of cloprostenol method for preparing the (+)-isomer of cloprostenol
PT85414A (en) Process for preparing cephalosporins and derivatives
IL88959A (en) Cephalosporin salts and injectable compositions
IL108134A0 (en) Cephalosporin salts and process for the preparation thereof
IL85637A0 (en) Cephalosporin derivatives and a process for the preparation thereof
DE3475710D1 (en) Cephalosporin derivatives and process for their preparation
YU41288A (en) Process for preparing disacharides derivatives
GB8814196D0 (en) New cepham compounds & process for preparation thereof
ZA894522B (en) Process for preparing arylsulphonyl-isocyanates and the addition derivatives thereof
HUT52371A (en) Process for producing composition against cardioarrhythmia